Harvard Business Review

OCTOBER 13, 2011

Risk management processes don't — but they should. The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Yet unlike in finance, where distributing risk across institutions is the goal, in drug development the focus is on isolating risk.

Banking 14

Banking Pharmaceuticals Microfinance Risk Management 14

Harvard Business Review

JANUARY 10, 2013

initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. The most notable was Fannie Mae's $10.8 billion restatement. In another instance, a new enforcement. The largest payments were from Pfizer ($2.3 billion) and GlaxoSmithKline ($3 billion).

Finance 12

Finance Banking Press Release Pharmaceuticals 12

Harvard Business Review

APRIL 16, 2012

This raises the question of whether retaining strategic cash makes economic sense and should be viewed as a legitimate corporate finance tool in today's environment. Strategic cash also can be used to finance long-term reinvestment programs in the business—which is especially valuable to companies in capital-intensive industries (e.g.,

Company 15

Company Cost of Capital Finance Long-term 15

Harvard Business Review

NOVEMBER 9, 2011

That's what we found when we studied the top management teams of companies in Europe over the past three years. Part of the problem may be in the backgrounds that companies desired: 85% of COOs had experience in operations, strategy, or finance. What role does he or she play in the organization?

COO 16

COO Sample Telecommunications Automotive 16

Harvard Business Review

JUNE 9, 2017

During our careers, we have worked in industry, academia, clinical medicine, and government and have managed successful academia-industry collaborations. These scenarios are seldom contemplated in institutional management of conflicts of interest. Our experiences in both sectors have led us to this conclusion. Practicing physicians.

Conflict of Interest 14

Conflict of Interest Pharmaceuticals Policies Industry 14

Harvard Business Review

FEBRUARY 23, 2011

The first part of the conference's message, that the infrastructure of the continent is greatly wanting, was a topic of many panels, including a pair of engaging ones on technology, but it was brought home most vividly in another context, by Thierry Tanoh , a vice president at the International Finance Corp.

Conference 15

Conference Pharmaceuticals Politics Entrepreneur 15

Harvard Business Review

AUGUST 23, 2012

For highly regulated sectors like finance, social media can be a legal minefield. These hurdles aren't unique to financial services — insurance, pharmaceuticals, health care and government all face regulation, to name a few examples. "Follow us here for updates on our work, our research, and our people.".

Compliance 17

Compliance Media Compliance Officer Policies 17

Harvard Business Review

MARCH 24, 2011

What makes the matter fascinating to industry watchers, approximately their equivalent of the Charlie Sheen supernova, is that Gupta served three terms as managing director of McKinsey & Co., In his tenure as McKinsey's worldwide managing director, Gupta displayed macher-like ambition not just for himself but even more so for his firm.

McKinsey 16

McKinsey Consultative Waterman Intellectual Capital 16

Harvard Business Review

OCTOBER 24, 2014

Here are some of the challenges that I’ve observed: Product management. In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations.

Products 11

Products Productivity Company Engineering 11

Harvard Business Review

JANUARY 26, 2011

Companies included in the ETF include major airlines, pharmaceuticals, industrials, and technology. After our meeting at the SSE, we had lunch with Dean Xiongwen Lu and Professor Cheng-Hua Tzeng of the Fudan School of Management. Eccles is a professor of management practice at HBS. Stay tuned.

Long-term 15

Long-term Sample Report Pharmaceuticals 15

Harvard Business Review

APRIL 5, 2012

A district sales manager says: "These district sales rankings are unfair. Coaching and performance management. If sales managers know account potential, they can coach salespeople on the best strategies for driving revenue growth. A salesperson says: "My quota is 10% higher than last year. For example: • Targeting.

Retail 12

Retail Incentives Tactics Pharmaceuticals 12

Harvard Business Review

SEPTEMBER 21, 2015

Not long ago, I worked with a client who was stepping into management for the first time. Terry, a highly regarded marketing associate in a pharmaceutical firm, had just been asked to lead a marketing team. Managing Yourself Book. For most new managers, making this transition to training and coaching isn’t easy.

Management 8

Management Learning-by-Doing Pharmaceuticals Marketing 8

Harvard Business Review

SEPTEMBER 13, 2011

Here are some common examples: When pharmaceutical companies announce that a new drug has been "approved," they are actually saying that their researchers made some breakthrough discoveries as far back as fifteen years ago.

Short-term 15

Short-term Pharmaceuticals Long-term Maturity 15

Harvard Business Review

SEPTEMBER 4, 2015

We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Pharmaceuticals. The data captured a 20-year period, from 1995 to 2014. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

MAY 26, 2014

While the managed care movement made a similar run in the early 1990s, the movement towards accountable care, bundled payments , and other population health efforts have not caused the type of backlash that managed care did ? in large part because most of these models have not meaningfully restricted patient choice.

Health Care 11

Health Care Venture Funding Entrepreneur Pharmaceuticals 11

Harvard Business Review

OCTOBER 25, 2018

The superstars tend to be more involved in global flows of trade and finance, more digitally mature, and they dominate the lists of the most valued companies, the most valued brands, the most desirable places to work, and the most innovative companies.

Industry 15

Industry Company GDP Bottom-up 15

Harvard Business Review

MARCH 14, 2017

In a recent Gallup poll , the pharmaceutical industry was the most widely disliked private industry, ranking even lower than lawyers. ” Meanwhile, the company recruited non-scientist talent from finance, consulting, tech, academia, and political campaigns and inserted them into drug-development roles.

Innovation 14

Innovation Company Incentives Industry 14

Harvard Business Review

SEPTEMBER 10, 2013

In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise. Finance Innovation' Executing on Innovation An HBR Insight Center. Innovation Isn''t an Idea Problem.

Venture Capitalist 9

Venture Capitalist Venture Funding Incentives Innovation 9

Harvard Business Review

OCTOBER 20, 2016

Meanwhile the Institute of International Finance forecasted net capital flows for emerging markets in 2015 would be negative for the first time since 1988. Each of these shifts have consequences for how today’s multinational corporations should manage themselves. This year, for example, the U.S. And in 2014, Pfizer, the U.S.

Globalization 8

Globalization Banking Policies Politics 8

Harvard Business Review

SEPTEMBER 10, 2013

In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise. Finance Innovation Insight Center_Innovation no-intromercial' Innovation Isn’t an Idea Problem.

Venture Capitalist 8

Venture Capitalist Venture Funding Incentives Innovation 8

Harvard Business Review

JUNE 29, 2015

If you ask someone who works in finance (as I had to) about PE and innovation, he or she will likely tell you that PE sponsors aren’t looking for the next big thing—they’re looking for companies that are dominant in a market, aren’t risky, and have a predictable and steady stream of cash to pay back debt.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

FEBRUARY 4, 2013

Perhaps surprisingly, two leading examples come from pharmaceutical companies. We're moving towards innovation in technology, pricing, business models and partnerships," explains head of corporate responsibility management, Dorje Mundle, of the company's base-of-the-pyramid operations. Breakthrough Finance.

EPS 10

EPS Innovation CEO Pharmaceuticals 10

Harvard Business Review

SEPTEMBER 19, 2016

You have to approach these problems as a manager and do the best analysis you can, including hard-headed financial analysis. Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. But perhaps managers have no choice. How should you make this decision?

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8

Harvard Business Review

JUNE 16, 2016

Pharmaceutical companies spend millions upon millions preparing meticulous plans for new drug launches – and yet their route-to-market strategies haven’t changed in decades, even though the reality of the market has. We must start to think differently about how business, management, and strategic intelligence works.

Planning 8

Planning Competitive Intelligence Pharmaceuticals Brand 8

Harvard Business Review

MAY 15, 2013

finance vs. marketing) and units (e.g. a fast-moving consumer products division vs. a pharmaceuticals division of a diversified firm). Depending on how acquisition and integration are managed, the legacy cultures of acquired units can persist for surprisingly long periods of time.

Incentives 9

Incentives Definition Pharmaceuticals System 9

Harvard Business Review

JANUARY 26, 2016

We recently conducted a survey of CI managers and analysts who’ve been through our training program to see how much their findings influenced major company decisions, and why. and European corporations, from CI-trained analysts in marketing, business development, strategy, R&D, finance, and other fields.

Competitive Intelligence 8

Competitive Intelligence Company CAPEX Analysis 8

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. This will not only challenge tax departments’ current calculations, but will also put increasing pressure on legal departments wrestling with IP asset and risk management. IP piracy will be another major complication.

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

FEBRUARY 20, 2014

But an awful lot of these jobs command very high-wages in law, finance, accounting, consulting, advertising, engineering, design, software, healthcare, scientific research, architecture, entertainment, hospitality, and many other areas. True, some of these are low-paying, burger-flipper jobs. The fact is, the end is not nigh. Far from it.

Intellectual Capital 9

Intellectual Capital Magazine Creativity Pharmaceuticals 9

Harvard Business Review

FEBRUARY 24, 2015

Conversely, the business may be an “unpolished diamond” that was neglected by its former management for too long and whose value is just waiting to be unlocked. Does the business have a complete, balanced, and cohesive management team? Are the management team and owners prepared to abandon business as usual?

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

FEBRUARY 26, 2013

For sales managers, this is not an easy question to answer. But when leaders take this conservative growth approach even when there is reasonable certainty of success and available financing, they undersize their sales forces and forfeit opportunity. The number of salespeople affects profitably by impacting both revenues and costs.

Company 8

Company Short-term Long-term Cost 8

Harvard Business Review

SEPTEMBER 5, 2016

Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. Finally, some companies have struggled to finance their activities without payment while they work on delivering the results, limiting their ability to innovate too.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

AUGUST 6, 2015

I made a career switch seven years ago, when I went from working as a reporter at the Financial Times , where I covered health care in the United States, to consulting — advising CEOs in the pharmaceutical industry on thought leadership and articulating their corporate strategies. Consider the legal field.

Career 8

Career Skills Health Care Pharmaceuticals 8

Harvard Business Review

AUGUST 23, 2016

Both Republicans and Democrats say the most effective board committee is audit/finance. Meanwhile, Democrats place greater importance on technology expertise and risk management. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g.,

Politics 8

Politics Committee Telecommunications Diversity 8

Harvard Business Review

MAY 5, 2016

sanctions are delaying these projects being financed. And Danish pharmaceutical company Novo Nordisk is building on its Iran presence by doubling local staff to nearly 300 and investing $76 million in a new factory. But managing expectations about the country’s trajectory is crucial for building an effective strategy.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Marshall Goldsmith

FEBRUARY 8, 2018

Thinkers50 – World’s Most Influential Management Thinkers. Called ‘The Academy Awards of Leadership’ by the Economist, Thinkers50 is the world’s most reliable resource for identifying, ranking and sharing the leading management ideas of our age. World authority on project management. Co-author: Predictable Magic.

Executive Coaching 70

Executive Coaching CEO Banking Magazine 70

Chartered Management Institute

FEBRUARY 26, 2024

In a hazardous world, managers can learn from the world of scuba diving: train hard, because you’ll never get rid of risk Scroll for more Shortcut to start of content Gareth Lock, founder of The Human Diver. Want to learn more about what diving can teach managers about navigating risk? Additional reporting by David Waller.

Uncertainty 52

Uncertainty Risk Management Training Learning-by-Doing 52

Strategy Driven

JANUARY 5, 2020

One such example is that of a large Swiss-based pharmaceutical company that invested around $11.3 Private businesses with pension funds have increased their commodities investment, especially through Exchange-traded funding. billion in platinum and other metals as well.

Price 66

Price Short-term Long-term Globalization 66